Rituxan (rituximab) - Roche
Cancer-Associated Retinopathy Presenting with Paraneoplastic Cerebellar Degeneration in Tonsillar Squamous Cell Carcinoma: A Case Report. (PubMed, Reports (MDPI)) - Sep 25, 2026 - "Treatment included robotic tonsillectomy with neck dissection, intravenous immunoglobulin, high-dose corticosteroids, and maintenance rituximab...Seven years later, he remains independent in activities of daily living despite the progression of retinal atrophy and cerebellar dysfunction; This case highlights the rare coexistence of CAR and seronegative PCD associated with tonsillar squamous cell carcinoma. Multimodal oncologic and immunosuppressive therapy produced meaningful neurologic and visual improvement, despite progressive long-term retinal degeneration." 
Journal • Ataxia • CNS Disorders • Immunology • Movement Disorders • Ocular Melanoma • Oncology • Ophthalmology • Otorhinolaryngology • Pain • Retinal Disorders • Squamous Cell Carcinoma
http://www.ncbi.nlm.nih.gov/pubmed/42784032
 
Bharat B Yarlagadda; David J Ramsey; Jayashri Srinivasan; Pooja Raibagkar; Yeseo Kwon
 
Sep 25, 2026
 
Prev Next